TGFB1 and neoplasm: In the initial stages, TGF-β inhibits tumor growth due to cell-cycle blockade in cells undergoing transformation and during the later stages become pro-tumorigenic due to resistance developed to the anti-proliferative activity of TGF-β by tumor cells [38].